Table 2 Prevalence and severity of asthma and asthma-associated symptoms among adolescents in Trinidad and Tobago
Prevalence, % | |||
|---|---|---|---|
Trinidad, n = 3519 | Tobago, n = 1469 | Relative Risk**, (95% CI) | |
% Participation | 73.3 | 92 | |
12 month prevalence | |||
wheeze | 13.1 | 13.4 | 0.98 (0.84–1.15) |
No. of attacks in past yr | |||
1–3 | 10.5 | 10.9 | 0.97 (0.81–1.15) |
4–12 | 1.9 | 3.0 | 0.65 (0.44–0.94) |
>12 | 0.9 | 1.8 | 0.51 (0.31–0.85) |
Sleep disturbance from wheeze | |||
≤1 per week | 4.7 | 5.8 | 0.81 (0.63–1.05) |
>1 per week | 2.7 | 5.1 | 0.53 (0.39–0.71) |
Speech limitation | 5.2 | 8.7 | 0.59 (0.47–0.74) |
Night cough in past year | 35.4 | 38.3 | 0.93 (0.86–1.00) |
Exercise-induced wheeze | 17.5 | 20.2 | 0.87 (0.76–0.98) |
Lifetime prevalence | |||
Wheeze | 24.1 | 24.3 | 0.99 (0.90–1.08) |
Asthma | 12.8 | 13.5 | 0.95 (0.82–1.12) |
Family History of Asthma | 23.0 | 13.4 | 1.72 (1.49–1.98) |